Tim Enns

Tim Enns is a seasoned biotechnology executive with over 30 years of experience in the pharmaceutical and biotechnology sectors. He currently serves as a Board Member at NanoValent Pharmaceuticals, Inc., a role he has held since October 2021. Prior to this, he was the President and CEO of the company from October 2016 to September 2021, where he was instrumental in advancing the company's oncology drug discovery and development initiatives, particularly its novel Targeted NanoSpheres technology.12

Enns has a diverse background in various leadership roles, including positions in sales, marketing, business development, and investor relations. He has worked with several biotechnology firms, helping them to improve their strategic marketing and investor outreach efforts. Notably, he has also held senior roles at Veeva Systems, where he focuses on enhancing the success of other companies through innovative tools and services.13

His educational background includes studies at Stanford University, which complements his extensive professional experience in the industry.1